Document |
Document Title |
WO/2018/229285A1 |
The present invention pertains to a process for the cross-ketonization (Piria reaction) between an aryl carboxylic acid and an aliphatic carboxylic acid using a metal-based compound and a slight or a moderate excess of aryl carboxylic ac...
|
WO/2018/230776A1 |
The present invention relates to compositions containing a pterosin compound and derivatives thereof as active ingredients for the prevention or treatment of degenerative brain diseases and, more specifically, to a pharmaceutical composi...
|
WO/2018/219560A1 |
The invention relates to a method for separating acetone from acetone/water mixtures, according to which a partial flow of the acetone/water mixture is concentrated in a column operating under positive pressure in order to obtain a produ...
|
WO/2018/214812A1 |
The present invention relates to a compound used as an autophagy regulator, and a preparation method therefor and uses thereof. Particularly, provided is a compound represented by general formula (I) or a pharmaceutically acceptable salt...
|
WO/2018/210971A1 |
The invention relates to a method for manufacturing 1,4-bis(4-phenoxybenzoylbenzene), comprising: - providing terephthaloyl chloride, diphenyl ether, a solvent and a Lewis acid, wherein the terephthaloyl chloride is of a purity grade suc...
|
WO/2018/210959A1 |
The invention relates to amethod for manufacturing 1,4-bis(4-phenoxybenzoylbenzene), comprising: providing a reactant mixture comprising terephthaloyl chloride, diphenyl ether and a Lewis acid in a solvent; reacting terephthaloyl chlorid...
|
WO/2018/211048A1 |
The invention relates to a method for manufacturing 1,4-bis(4-phenoxybenzoylbenzene), comprising: reacting terephthaloyl chloride with diphenyl ether in a reaction solvent and in the presence of a Lewis acid, so as to obtain a product mi...
|
WO/2018/210963A1 |
The invention relates to a method for manufacturing 1,4-bis(4-phenoxybenzoylbenzene), comprising: - providing a reactant mixture comprising terephthaloyl chloride and diphenyl ether in a solvent; - adding a Lewis acid to the reactant mix...
|
WO/2018/211045A1 |
The invention relates to a method for manufacturing 1,4-bis(4- phenoxybenzoylbenzene), comprising: –reacting terephthaloyl chloride with diphenyl ether in a reaction solvent and in the presence of a Lewis acid, so as to obtain a produc...
|
WO/2018/211046A1 |
The invention relates to a method for manufacturing 1,4-bis(4- phenoxybenzoylbenzene), comprising: –reacting terephthaloyl chloride with diphenyl ether in a reaction solvent and in the presence of a Lewis acid, so as to obtain a produc...
|
WO/2018/207910A1 |
The purpose of the present invention is to provide a composition which has an anti-inflammatory effect. An anti-inflammatory composition according to the present invention contains a compound represented by formula 1 as an active ingredi...
|
WO/2018/197325A1 |
The present invention refers to a process for the preparation of an α-functionalized ketone, an α-functionalized ketone obtained by said process, a photopolymerizable composition comprising the α-functionalized ketone and at least one...
|
WO/2018/191522A1 |
The present disclosure provides methods of treating polycystic ovary syndrome (PCOS) with tetrahydro-iso-alpha acid (THIAA) derivatives and substantially enantiomerically pure compositions and pharmaceutical formulations thereof, in part...
|
WO/2018/185010A1 |
The present invention relates to compound of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein the dotted lines represent a carbon-carbon single bond or a carbon-carbon a double bond; and one R1 gr...
|
WO/2018/185012A1 |
The present invention relates to trans isomers of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein the bold and hatched lines indicate a relative or absolute configuration; and their uses as perfu...
|
WO/2018/181865A1 |
The present invention provides a novel cationic ruthenium complex which is easy to produce and handle and can be procured at a relatively low cost and a production method for the ruthenium complex, a method for producing an alcohol or th...
|
WO/2018/171305A1 |
The present application discloses a process and an industrialized production device for co-production of environmentally friendly insulating gases. The co-production process comprises: 1) conducting a contact reaction of oxygen and HFP i...
|
WO/2018/167264A1 |
The present invention relates to a phenalene-1-one compound, a photosensitizer composition comprising said phenalene-1-one compound, an article comprising said phenalene-1-one compound and/or photosensitizer composition and the use thereof.
|
WO/2018/155484A1 |
Disclosed are: a phosphine oxide compound represented by formula (I), in which n represents an integer of 3 or higher, Ar1 represents an aromatic group of valence n, L represents a divalent linker group, and Ar2 and Ar3 each independentl...
|
WO/2018/155557A1 |
Disclosed is a rare earth complex which comprises a rare earth ion and a ligand that is coordinated to the rare earth ion and has a fused polycyclic aromatic group. The fused polycyclic aromatic group is a residue that is obtained by rem...
|
WO/2018/153499A1 |
A primary aspect of the present invention relates to a method for producing a mixture comprising rotundone. A further aspect of the present invention relates to rotundone-containing mixtures and to the use thereof for creating, imparting...
|
WO/2018/149370A1 |
Disclosed are a fluorenylaminoketone photoinitiator, a preparation method thereof and a UV photocurable composition containing same. The photoinitiator comprises a compound having a structure as shown in general formula (I) or a derivati...
|
WO/2018/141771A1 |
The invention relates to a method for producing cyclododecanone (CDON). During the production, contaminated cyclododecane (CDAN) is produced. This can be separated from CDON by distillation (CDAN-containing fraction). The separation of C...
|
WO/2018/140339A1 |
Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Y is defined herein. Also disclosed are methods for reducing the glycem...
|
WO/2018/138369A1 |
The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3,R4, R5, R6, R7 and X ha...
|
WO/2018/135395A1 |
An electrolytic solution for non-aqueous secondary batteries, which comprises an electrolyte, an organic solvent and a metal complex represented by general formula (I); a non-aqueous secondary battery using the electrolytic solution for ...
|
WO/2018/133473A1 |
Provided in the present invention is a direct oxidation method for a saturated carbon hydrogen bond in an organic compound, comprising: under conditions of visible light irradiation, reacting the organic compound with an oxidising reagen...
|
WO/2018/134278A1 |
The present invention refers to a new process for the synthesis of (9β,10α)-pregn-4-ene-3,20-dione, commonly known as retroprogesterone, having the formula (1) shown below.
|
WO/2018/136218A1 |
Catalysts and methods are provided for producing high yields of butene. The inventive catalysts are bifunctional catalysts having both hydrogenation and dehydration functionalities. Preferred catalysts generally comprise elemental copper...
|
WO/2018/136792A1 |
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.
|
WO/2018/128959A1 |
A process comprising: a) hydrogenating an aromatic compound comprising an aromatic ring and a substitutable hydrogen atom on said aromatic ring to form optionally substituted cyclohexene; b) contacting the cyclohexene with an oxidant und...
|
WO/2018/128960A1 |
A process comprising: a) contacting an aromatic compound comprising an aromatic ring and a substitutable hydrogen atom on said aromatic ring with an oxidation catalyst and an oxidant under conditions effective to hydroxylate the aromatic...
|
WO/2018/123649A1 |
A 1, 2, 2, 2–tetrafluorethyl methyl ether being a synthetic intermediate of desflurane was conveniently obtained by causing a trimethyl orthoformate to act on a fluoral obtained by a gas phase fluorination reaction of chloral, in the p...
|
WO/2018/124148A1 |
The purpose of the present invention relates to providing a novel glyceric acid ester which can be produced at a high yield and for which use as a synthesis intermediate can be expected, and a method for producing same. The purpose of th...
|
WO/2018/122689A1 |
Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL).
|
WO/2018/124149A1 |
The purpose of the present invention is to provide a method for producing glyceric acid ester that enables easy, high-yield production and makes it easy to reuse pyridines that are used for a reaction. Provided is a method for producing ...
|
WO/2018/124147A1 |
The present invention relates to a method for manufacturing 1,3-dioxane-5-ones by a short and simple method from raw materials that can be obtained easily and inexpensively, using 1,3-dioxane, which is a mixture with 1,3-dioxalans, as a ...
|
WO/2018/115034A1 |
Disclosed are methods of decreasing the concentration of a metal in a monomer composition including a bis(benzoyl)benzene, bis(benzoyl)benzene monomer compositions having a low total metal concentration, di-ketone polymers made from low ...
|
WO/2018/114732A1 |
The present invention relates to a new process for the preparation of one of the enantiomers of 3,4-dihydroxy-2,6,6-trimethylcyclohex-2-enoneand to a process for preparing (3S,3'S)-astaxanthin, which comprises the step of providing the (...
|
WO/2018/107929A1 |
A curable compound which has good solvent solubility and which may form a cured product having super-heat resistance, the structure thereof is represented by the following formula (1). In formula (1), R1 and R2 represent curable function...
|
WO/2018/109621A1 |
A novel organometallic complex with high emission efficiency is provided. The organometallic complex, which is represented by General Formula (G1), includes iridium and a ligand including an aryl group including a cyano group at the 1-po...
|
WO/2018/109872A1 |
The present invention provides an industrially desirable novel cyclopentenone derivative and a method for producing the same. Practical and industrial applications of the following are anticipated: the novel compounds (formulas (I) and (...
|
WO/2018/105237A1 |
A novel method for producing a trioxopropane compound is provided. The present invention provides a method for producing a trioxopropane compound represented by general formula (1), the method being characterized by reacting a dioxopropa...
|
WO/2018/101057A1 |
Provided are a compound useful as a mold release agent, a mold release agent containing same, a curable composition, and a nanoimprint lithography resin material. Specifically, the present invention provides: a calixarene compound with a...
|
WO/2018/095495A1 |
A photoinitiator is provided which incorporates a camphorquinone photoinitiator moiety.
|
WO/2018/090200A1 |
Disclosed is a method for preparing isophorone by means of organic catalysis. Acetone is used as a starting material, and undergoes liquid phase condensation reaction under the catalytic action of a catalyst, i.e., organic urotropine-bas...
|
WO/2018/091622A1 |
The present invention is directed towards an industrial sustainable process for the manufacture of gamma, delta-unsaturated ketones of formula (III ) in the presence of novel catalysts of formula (IV), wherein R1 is methyl or ethyl, R3 i...
|
WO/2018/091624A1 |
The present invention is directed towards a process for the manufacture of gamma, delta-unsaturated ketones of the general formula (III) by reacting a tertiary vinyl carbinol of the general formula (I) with an isopropenyl alkyl ether of ...
|
WO/2018/090199A1 |
Disclosed is a method for preparing isophorone by means of organic catalysis. .Acetone is used as a starting material, and undergoes liquid phase condensation reaction under the catalytic action of a catalyst, i.e., organic imidazole-bas...
|
WO/2018/090717A1 |
Provided are an ATG analogue, a preparation method therefor and a use thereof, the specific structure of the ATG analogue is as shown in the following three general formulae: formula (I), formula (II), and formula (III) wherein X/Y/Z can...
|